Similarly, levels of SPON2, an ECM protein involved in innate immunity, correlate with DN severity in T2DM patients 45; we observed increased Spon2 levels in the diabetic kidney that were reversed by pioglitazone treatment. This evidence concerns the gene SPON2 and type 2 diabetes mellitus.